All News

Falls are a risk for everyone during slushy winter months, but the risk is especially high for people with cancer. Memorial Sloan Kettering physical therapist Jillian Hobson walks readers through what they can do to minimize the chance of falling.

Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider.

A male breast cancer survivor examines the invisibility factor in this disease.

Patients with unresectable or metastatic HER2-positive breast cancer now have a new treatment option.

They're billed as "nothing", but for this patient with cancer, the tattoos are daily reminders of her new life.

From a newly proposed rule to help lower prescription drug prices to an oncology nurse and a patient with cancer singing “O Holy Night,” here’s what is making headlines in the cancer space this week.

One patient provides potential caregivers “a guide to help you help me”.

The Food and Drug Administration approved Padcev for the treatment of adult patients with locally advanced or metastatic urothelial cancer who have received prior treatment with a PD-1/PD-L1 inhibitor and platinum-containing chemotherapy.

Radiofrequency ablation was statistically on par with surgery when it came to survival after an early recurrence of liver cancer, but surgery provided more benefit if the disease was a bit more advanced.

Some beauty products could contain harmful ingredients. For the person with cancer, it’s important to know which options are the safest.

One expert discusses exciting advances in using drug combinations to treat metastatic melanoma.

Whether we have cancer or not, gratitude enriches our lives and there are many things to be grateful for.

Patients with hepatocellular carcinoma whose tumors couldn’t be surgically removed lived longer and experienced few side effects after stereotactic body radiotherapy, according to phase 2 study findings.

The Food and Drug Administration approved Xtandi for the treatment of patients with metastatic castration-sensitive prostate cancer.

Fast track designation has been granted for the investigational therapy tipifarnib to treat patients with HRAS mutant head and neck squamous cell carcinomas.

Two-time cancer survivor gratefully shares her gratitude and discusses how they are getting better at helping cancer patients.

Patients with head and neck cancer who received acupuncture during therapy saw lower incidence and severity of dry mouth compared with those who received oral health education.

Two-time cancer survivor reviews some of the questions about genetic testing for other cancer survivors.

However, the recent addition of new chemotherapy-free options such as chimeric antigen receptor (CAR)-T cell therapy could offer hope for patients with mantle cell lymphoma who develop resistance to chemotherapy-based treatment.